Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics

Y Kanai - Pharmacology & therapeutics, 2022 - Elsevier
Cancer cells require a massive supply of nutrients, including sugars and amino acids—the
upregulation of transporters for each nutrient contributes to meet the demand. Distinct from …

Membrane transporters in drug development and as determinants of precision medicine

A Galetin, KLR Brouwer, D Tweedie… - Nature Reviews Drug …, 2024 - nature.com
The effect of membrane transporters on drug disposition, efficacy and safety is now well
recognized. Since the initial publication from the International Transporter Consortium …

Sampling alternative conformational states of transporters and receptors with AlphaFold2

D Del Alamo, D Sala, HS Mchaourab, J Meiler - Elife, 2022 - elifesciences.org
Equilibrium fluctuations and triggered conformational changes often underlie the functional
cycles of membrane proteins. For example, transporters mediate the passage of molecules …

Structural and functional annotation of solute carrier transporters: implication for drug discovery

V Dvorak, G Superti-Furga - Expert Opinion on Drug Discovery, 2023 - Taylor & Francis
ABSTRACT Introduction Solute carriers (SLCs) represent the largest group of membrane
transporters in the human genome. They play a central role in controlling the …

Integrated AlphaFold2 and DEER investigation of the conformational dynamics of a pH-dependent APC antiporter

D Del Alamo, L DeSousa, RM Nair… - Proceedings of the …, 2022 - National Acad Sciences
The Amino Acid–Polyamine-Organocation (APC) transporter GadC contributes to the
survival of pathogenic bacteria under extreme acid stress by exchanging extracellular …

Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells

K Nishikubo, R Ohgaki, H Okanishi… - Journal of Cellular …, 2022 - Wiley Online Library
L‐type amino acid transporter 1 (LAT1; SLC7A5), which preferentially transports large
neutral amino acids, is highly upregulated in various cancers. LAT1 supplies cancer cells …

New and emerging research on solute carrier and ATP binding cassette transporters in drug discovery and development: outlook from the international transporter …

KM Giacomini, SW Yee, ML Koleske… - Clinical …, 2022 - Wiley Online Library
Enabled by a plethora of new technologies, research in membrane transporters has
exploded in the past decade. The goal of this state‐of‐the‐art article is to describe recent …

Principles of alternating access in LeuT-fold transporters: commonalities and divergences

D Del Alamo, J Meiler, HS Mchaourab - Journal of Molecular Biology, 2022 - Elsevier
Found in all domains of life, transporters belonging to the LeuT-fold class mediate the import
and exchange of hydrophilic and charged compounds such as amino acids, metals, and …

The human LAT1–4F2hc (SLC7A5–SLC3A2) transporter complex: Physiological and pathophysiological implications

J Kahlhofer, D Teis - Basic & Clinical Pharmacology & …, 2023 - Wiley Online Library
LAT1 and 4F2hc form a heterodimeric membrane protein complex, which functions as one of
the best characterized amino acid transporters. Since LAT1–4F2hc is required for the …

Structural basis for substrate specificity of heteromeric transporters of neutral amino acids

CF Rodriguez, P Escudero-Bravo… - Proceedings of the …, 2021 - National Acad Sciences
Despite having similar structures, each member of the heteromeric amino acid transporter
(HAT) family shows exquisite preference for the exchange of certain amino acids. Substrate …